A range of corporates contributed to electric carmaker Aion’s $2.5bn series A round while Prosus took part in a $46m series E for farming services provider DeHaat.

The European industrial group has formed a unit which will invest in early-stage life sciences and biotech developers through a team headed by Paolo Di Giorgio.

AbbVie is acquiring Amgen-backed DJS Antibodies for $255m while Legend Holdings took part in a $56.6m series C round for VectorBuilder.

Cyberdontics' series A round is that rarest of things - a VC investment by a dental company. Why has the sector been underserved, and could it be about to change?

Chengtun Mining Group took part in Hithium’s $278m series B round while HubSpot Ventures contributed to Jasper’s $125m series A.

Google was among the investors that helped lift Progcap’ series C round to $120m while Okta Ventures boosted Hycu’s $53m series B.

Thomas Reuters and Siemens participated in DataGrail’s $45m series C round while AyoConnect boosted its series B to $25m.

Consumer credit provider FinAccel secured $140m from investors including GMO Payment Gateway while Amgen helped brain disease drug developer Neumora raise $112m.

Salesforce, ANZ and Tencent helped Airwallex boost its series E round to $300m while Hermes-Epitek chipped into a $30m series A for Ochre Bio.

BBC Studios bought portfolio company Firebird Pictures while SoftBank Vision Fund 2 led a nine-figure round for dental product maker SprintRay.